ACHV (Achieve Life Sciences Inc) Wutah bathi ing taun lumaku

Simbol resmi perusahaan Achieve Life Sciences Inc (ACHV)

Year-over-year EPS growth rates on this GURU.Markets chart capture yield dynamics, where the value -16.50 records this metric. Patent protection for Cytisinicline and FDA trials create a formidable barrier to entry for competitors. Achieve Life Sciences (ACHV) relies on future sales of its innovative smoking cessation treatment, while strong clinical data for Cytisinicline promise a stable cash generator.

Achieve Life Sciences Inc. (ACHV): Wutah bathi ing taun lumaku saka 04.07.2022 nganti 10.11.2026

Rincian metrik keuangan lan pasar Achieve Life Sciences Inc (ACHV)

Ringkesan analisis perusahaan:Achieve Life Sciences, Inc, ACHV
Produk seri Achieve Life Sciences, Inc

The development of an innovative drug for nicotine addiction makes Achieve Life Sciences (ACHV) dependent on capital expenditures, which is reflected in its net income dynamics. This YoY net income per share growth rate measures the annual growth pace of earnings per share, allowing investors to assess the issuer's actual financial resilience to market shocks through the analysis of the YoY net income per share growth rate.